Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

About 91% of patients treated with the drug tested negative for COVID-19 in standard RT-PCR tests by day seven, compared to nearly 79% who were given the standard of care, the company said citing Phase-III clinical trial data. The drug, known as Pegylated Interferon alpha-2b and branded as 'PegiHep' by Cadila, was originally approved for liver disease Hepatitis C and launched in India 10 years ago.

Reuters | Updated: 05-04-2021 09:00 IST | Created: 05-04-2021 09:00 IST
Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

India's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.

A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said in a statement to stock exchanges. About 91% of patients treated with the drug tested negative for COVID-19 in standard RT-PCR tests by day seven, compared to nearly 79% who were given the standard of care, the company said citing Phase-III clinical trial data.

The drug, known as Pegylated Interferon alpha-2b and branded as 'PegiHep' by Cadila, was originally approved for liver disease Hepatitis C and launched in India 10 years ago. It is being repurposed to treat COVID-19. The news comes as daily coronavirus infections are surging to new highs in India, which has the world's third-highest caseload after the United States and Brazil. India has so far reported close to 12.5 million infections and more than 164,000 deaths.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Investor group in exclusive talks to acquire Forbes for $650 mln -source

An investor group led by U.S. merchant bank GSVs CEO Michael Moe has entered into exclusive negotiations to acquire business news and information publisher Forbes Media LLC for about 650 million, a person familiar with the matter said on We...

Spain finds 11 cases of variant first identified in India

Spains health minister says the European country has detected 11 cases of the new strain of the coronavirus first identified in India.Minister Carolina Darias says the cases were two separate outbreaks discovered by health officials in rece...

COVID-19: Haryana announces medical aid for BPL patients

While reiterating his commitment that every needy has the first right on the government, Haryana Chief Minister Manohar Lal Khattar has announced to give medical assistance to the Below Poverty Line BPL families so that needy or poor person...

Winter Pasture: Book describing hardships endured by ethnic Kazakh herders of Xinjiang now available to wider audience

The hardships of Kazakh herders of Xinjiang in China depicted in the book Winter Pasture will soon be available to a wider audience as the book, first published in 2012 by author Li Juan, has been released in English this year, reported The...

Give Feedback